ROXANA RAMOS: Open Payments
NPI 1700651197 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 53 payments from 29 companies in 2025. Trend: 2023 $547 · 2024 $1,469 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $163 |
| Daiichi Sankyo Inc. | 7 | $156 |
| Pharmacosmos Therapeutics Inc. | 2 | $152 |
| Janssen Biotech, Inc. | 4 | $141 |
| ABBVIE INC. | 7 | $131 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Spectrum Pharmaceuticals Inc. | 2 | $38 |
| BeOne Medicines USA, Inc. | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
Products named: RYBREVANT, REBLOZYL, COSELA, Enhertu, EPKINLY, DATROWAY, Nubeqa, CALQUENCE.
Industry payments across PA — which companies pay providers there.
